Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The purpose of this study is to evaluate the efficacy (reduction of major ischemic events at 6 and 12 months of follow-up) of a tailored clopidogrel therapy in patients with UA/NSTEMI undergoing PCI with stent implantation and wiht a documented residual platelet reactivity assessed by a point of care system (VerifyNow P2Y12).
Epistemonikos ID: 51c119a6f7c0e0bb372f121fff16819582e455f7
First added on: May 05, 2024